Sign in

CIK 0000318154

  • Large accelerated filer
Ticker
AMGN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
953540776
Phone
+1 805-447-1000
Business address
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA, 91320
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-05-07 Busch Matthew C. VP, Finance & CAO Grant or award +333 4,932
2024-05-07 Busch Matthew C. VP, Finance & CAO Grant or award · Nqso (Right to Buy) +2,163 $300.30 $650K 2,163
2024-05-05 Busch Matthew C. VP, Finance & CAO Shares withheld for taxes −27 $311.29 $8K 4,599
2024-05-02 Busch Matthew C. VP, Finance & CAO Shares withheld for taxes −27 $277.37 $7K 4,626
2024-04-30 Busch Matthew C. VP, Finance & CAO Shares withheld for taxes −17 $276.38 $5K 4,653
2024-03-18 Busch Matthew C. VP, Finance & CAO Shares withheld for taxes −146 $268.87 $39K 4,670
2024-03-06 Busch Matthew C. VP, Finance & CAO Grant or award +418 4,799
2023-11-05 Busch Matthew C. VP, Finance & CAO Shares withheld for taxes −66 $269.86 $18K 4,550
2023-11-05 Busch Matthew C. VP, Finance & CAO Shares withheld for taxes −183 $269.86 $49K 4,367

Page 2 of 2 · 29 trades